Skip to main content

Advertisement

Log in

Bone marrow mesenchymal stem cells-derived exosomes containing miR-539-5p inhibit pyroptosis through NLRP3/caspase-1 signalling to alleviate inflammatory bowel disease

  • Original Research Article
  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

Background

Exosomes derived from bone mesenchymal stem cells (BMSCs) are potential candidates for inflammatory bowel disease (IBD) treatment. The present study investigated the therapeutic effect and potential mechanism of BMSCs-derived exosomes on pyroptosis in IBD.

Methods

We induced IBD in mice and cell models through dextran sulfate sodium (DSS) and LPS, respectively. The mRNA and protein expression levels were assessed by qRT–PCR, Western blotting, IF and IHC. The concentrations of IL-1β, IL-18 and TNFα were assessed using ELISA. ROS levels were determined using DCFH-DA staining. Cell proliferation of mIECs was analysed using an MTT assay. In addition, a flow cytometry assay was performed to detect pyroptosis. Finally, the binding relationship between miR-539-5p and NLRP3 was verified by a dual luciferase reporter gene assay.

Results

Our results revealed that intraperitoneal injection of BMSCs-derived exosomes inhibited DSS-induced pyroptosis as well as IBD symptoms in mice. In addition, BMSCs-derived exosome treatment suppressed pyroptosis, ROS levels and the concentrations of proinflammatory cytokines (IL-1β, IL-18 and TNFα) in LPS-treated mIECs in a miR-539-5p-dependent manner. Further research found that miR-539-5p suppressed NLRP3 expression in mIECs by directly targeting NLRP3. As expected, pyroptosis in LPS-treated mIECs was significantly reduced by NLRP3 knockdown. In addition, NLRP3 silencing restored the inhibitory effect of exosomes derived from BMSCs transfected with miR-539-5p inhibitor on pyroptosis in LPS-treated mIECs.

Conclusion

The present study demonstrated that BMSCs-derived exosomal miR-539-5p suppresses pyroptosis through NLRP3/caspase-1 signalling to inhibit IBD progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

IBD:

Inflammatory bowel disease

UC:

Ulcerative colitis

CD:

Crohn’s disease

MCSs:

Mesenchymal stem cells

BMSCs:

Bone marrow mesenchymal stem cells

miRNAs:

MicroRNAs

PYD:

Pyrin domain

NLRP3:

Nucleotide-binding domain-like receptor family member pyrin domain-containing protein 3

ASC:

Apoptosis-associated speck-like protein containing CARD

GSDMD:

Gasdermin D

ROS:

Reactive oxygen species

TEM:

Transmission electron microscopy

MTT:

3-(4,5-Dimethylthiazolyl2)-2,5-diphenyltetrazolium bromide

qRT–PCR:

Quantitative real-time polymerase chain reaction

DSS:

Dextran sulfate sodium salt

TNF-α:

Tumour necrosis factor-α

IL:

Interleukin

LPS:

Lipopolysaccharide

IF:

Immunofluorescence

HE:

Haematoxylin–eosin

SD:

Standard deviation

ANOVA:

Analysis of variance

DMELM:

Dulbecco's modified Eagle’s medium

ELISA:

Enzyme-linked immunosorbent assay

IHC:

Immunohistochemistry

References

  1. Márquez L, Shen C, Cleynen I, De Hertogh G, Van Steen K, Machiels K, et al. Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis. Gut. 2012;61:528–34.

    Article  Google Scholar 

  2. Sairenji T, Collins KL, Evans DV. An update on inflammatory bowel disease. Prim Care. 2017;44:673–92.

    Article  Google Scholar 

  3. Itzkowitz SH, Yio X. Inflammation and cancer IV Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol. 2004;287:7–17.

    Article  Google Scholar 

  4. Yang J, Liu XX, Fan H, Tang Q, Shou ZX, Zuo DM, et al. Extracellular vesicles derived from bone marrow mesenchymal stem cells protect against experimental colitis via attenuating colon inflammation, oxidative stress and apoptosis. PLoS ONE. 2015;10: e0140551.

    Article  Google Scholar 

  5. Chen X, Liu G, Yuan Y, Wu G, Wang S, Yuan L. NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-κB signaling. Cell Death Dis. 2019;10:906.

    Article  CAS  Google Scholar 

  6. Xiong Y, Lou Y, Su H, Fu Y, Kong J. Cholecalciterol cholesterol emulsion ameliorates experimental colitis via down-regulating the pyroptosis signaling pathway. Exp Mol Pathol. 2016;100:386–92.

    Article  CAS  Google Scholar 

  7. Yuan YY, Xie KX, Wang SL, Yuan LW. Inflammatory caspase-related pyroptosis: mechanism, regulation and therapeutic potential for inflammatory bowel disease. Gastroenterol Rep. 2018;6:167–76.

    Article  Google Scholar 

  8. Pelekanos RA, Li J, Gongora M, Chandrakanthan V, Scown J, Suhaimi N, et al. Comprehensive transcriptome and immunophenotype analysis of renal and cardiac MSC-like populations supports strong congruence with bone marrow MSC despite maintenance of distinct identities. Stem cell Res. 2012;8:58–73.

    Article  CAS  Google Scholar 

  9. Weiss ML, Anderson C, Medicetty S, Seshareddy KB, Weiss RJ, VanderWerff I, et al. Immune properties of human umbilical cord Wharton’s jelly-derived cells. Stem Cells (Dayton, Ohio). 2008;26:2865–74.

    Article  CAS  Google Scholar 

  10. Mohanty A, Polisetti N, Vemuganti GK. Immunomodulatory properties of bone marrow mesenchymal stem cells. J Biosci. 2020;45:2.

    Article  Google Scholar 

  11. Kagia A, Tzetis M, Kanavakis E, Perrea D, Sfougataki I, Mertzanian A, et al. Therapeutic effects of mesenchymal stem cells derived from bone marrow, umbilical cord blood, and pluripotent stem cells in a mouse model of chemically induced inflammatory bowel disease. Inflammation. 2019;42:1730–40.

    Article  CAS  Google Scholar 

  12. Park JS, Yi TG, Park JM, Han YM, Kim JH, Shin DH, et al. Therapeutic effects of mouse bone marrow-derived clonal mesenchymal stem cells in a mouse model of inflammatory bowel disease. J Clin Biochem Nutr. 2015;57:192–203.

    Article  CAS  Google Scholar 

  13. Nakano M, Nagaishi K, Konari N, Saito Y, Chikenji T, Mizue Y, et al. Bone marrow-derived mesenchymal stem cells improve diabetes-induced cognitive impairment by exosome transfer into damaged neurons and astrocytes. Sci Rep. 2016;6:24805.

    Article  CAS  Google Scholar 

  14. Doeppner TR, Herz J, Görgens A, Schlechter J, Ludwig AK, Radtke S, et al. Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl Med. 2015;4:1131–43.

    Article  CAS  Google Scholar 

  15. Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells (Dayton, Ohio). 2017;35:851–8.

    Article  CAS  Google Scholar 

  16. Zhang B, Shen L, Shi H, Pan Z, Wu L, Yan Y, et al. Exosomes from human umbilical cord mesenchymal stem cells: identification, purification, and biological characteristics. Stem Cells Int. 2016;2016:1929536.

    PubMed  PubMed Central  Google Scholar 

  17. Wood MJ, O’Loughlin AJ, Samira L. Exosomes and the blood-brain barrier: implications for neurological diseases. Ther Deliv. 2011;2:1095–9.

    Article  CAS  Google Scholar 

  18. Wang G, Yuan J, Cai X, Xu Z, Wang J, Ocansey DKW, et al. HucMSC-exosomes carrying miR-326 inhibit neddylation to relieve inflammatory bowel disease in mice. Clin Transl Med. 2020;10: e113.

    PubMed  PubMed Central  Google Scholar 

  19. Sun D, Cao H, Yang L, Lin L, Hou B, Zheng W, et al. MiR-200b in heme oxygenase-1-modified bone marrow mesenchymal stem cell-derived exosomes alleviates inflammatory injury of intestinal epithelial cells by targeting high mobility group box 3. Cell Death Dis. 2020;11:480.

    Article  CAS  Google Scholar 

  20. Meng L, Cao H, Wan C, Jiang L. MiR-539-5p alleviates sepsis-induced acute lung injury by targeting ROCK1. Folia Histochem Cytobiol. 2019;57:168–78.

    Article  CAS  Google Scholar 

  21. Shi J, Zhao Y, Wang Y, Gao W, Ding J, Li P, et al. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature. 2014;514:187–92.

    Article  CAS  Google Scholar 

  22. Yang Y, Liu PY, Bao W, Chen SJ, Wu FS, Zhu PY. Hydrogen inhibits endometrial cancer growth via a ROS/NLRP3/caspase-1/GSDMD-mediated pyroptotic pathway. BMC Cancer. 2020;20:28.

    Article  CAS  Google Scholar 

  23. Gaidt MM, Ebert TS, Chauhan D, Schmidt T, Schmid-Burgk JL, Rapino F, et al. Human monocytes engage an alternative inflammasome pathway. Immunity. 2016;44:833–46.

    Article  CAS  Google Scholar 

  24. Yin Y, Wu RX, He XT, Xu XY, Wang J, Chen FM. Influences of age-related changes in mesenchymal stem cells on macrophages during in-vitro culture. Stem Cell Res Ther. 2017;8:153.

    Article  Google Scholar 

  25. Governa P, Marchi M, Cocetta V, De Leo B, Saunders PTK, Catanzaro D, et al. Effects of Boswellia Serrata Roxb. and Curcuma longa L. in an in vitro intestinal inflammation model using immune cells and Caco-2. Pharmaceuticals. 2018;11:2.

    Article  Google Scholar 

  26. Nunes NS, Chandran P, Sundby M, Visioli F, da Costa GF, Burks SR, et al. Therapeutic ultrasound attenuates DSS-induced colitis through the cholinergic anti-inflammatory pathway. EBioMedicine. 2019;45:495–510.

    Article  Google Scholar 

  27. Subramanian S, Geng H, Tan XD. Cell death of intestinal epithelial cells in intestinal diseases. Sheng li xue bao : [Acta physiologica Sinica]. 2020;72:308–24.

    Google Scholar 

  28. Block GJ, Ohkouchi S, Fung F, Frenkel J, Gregory C, Pochampally R, et al. Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1. Stem Cells (Dayton, Ohio). 2009;27:670–81.

    Article  CAS  Google Scholar 

  29. Chen TS, Lai RC, Lee MM, Choo AB, Lee CN, Lim SK. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res. 2010;38:215–24.

    Article  CAS  Google Scholar 

  30. Yang S, Liang X, Song J, Li C, Liu A, Luo Y, et al. A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6. Stem Cell Res Ther. 2021;12:315.

    Article  Google Scholar 

  31. Heidari N, Abbasi-Kenarsari H, Namaki S, Baghaei K, Zali MR, Ghaffari Khaligh S, et al. Adipose-derived mesenchymal stem cell-secreted exosome alleviates dextran sulfate sodium-induced acute colitis by Treg cell induction and inflammatory cytokine reduction. J Cell Physiol. 2021;236:5906–20.

    Article  CAS  Google Scholar 

  32. Basu J, Ludlow JW. Exosomes for repair, regeneration and rejuvenation. Expert Opin Biol Ther. 2016;16:489–506.

    Article  CAS  Google Scholar 

  33. Li Z, Wu G, Li J, Wang Y, Ju X, Jiang W. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC. BMC Cancer. 2020;20:282.

    Article  Google Scholar 

  34. Guo J, Cai H, Liu X, Zheng J, Liu Y, Gong W, et al. Long non-coding RNA LINC00339 stimulates glioma vasculogenic mimicry formation by regulating the miR-539-5p/TWIST1/MMPs axis. Mol Therapy Nucl Acids. 2018;10:170–86.

    Article  CAS  Google Scholar 

  35. Mezzasoma L, Antognelli C, Talesa VN. Atrial natriuretic peptide down-regulates LPS/ATP-mediated IL-1β release by inhibiting NF-kB, NLRP3 inflammasome and caspase-1 activation in THP-1 cells. Immunol Res. 2016;64:303–12.

    Article  CAS  Google Scholar 

  36. Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526:660–5.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to give our sincere gratitude to the reviewers for their constructive comments.

Funding

This work was supported by Shandong Traditional Chinese Medicine Science and Technology Development Project (No. 2019-0397), Special funding sponsorship of Shandong Province Traditional Chinese Medicine High-level Talent Cultivation Project and Qilu Health Leading Talents Training Project Special Fund.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lize Zhang.

Ethics declarations

Conflicts of interest

All authors agree with the presented findings, have contributed to the work, and declare no conflict of interest.

Ethics approval and consent to participate

The third-generation BMSCs were used for experiments. This study was approved by the The Affiliated Hospital of Qingdao University ethics committee. All animal experiments and protocols were reviewed and approved by the Animal Care and Use Committee of The Affiliated Hospital of Qingdao University.

Additional information

Responsible Editor: H. Wang.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, D., Xue, H., Tan, J. et al. Bone marrow mesenchymal stem cells-derived exosomes containing miR-539-5p inhibit pyroptosis through NLRP3/caspase-1 signalling to alleviate inflammatory bowel disease. Inflamm. Res. 71, 833–846 (2022). https://doi.org/10.1007/s00011-022-01577-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00011-022-01577-z

Keywords

Navigation